Related Experiment Video
Updated: Feb 4, 2026

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
Characterizing the protective effects of SHLP2, a mitochondrial-derived peptide, in macular degeneration
Sonali Nashine1, Pinchas Cohen2, Anthony B Nesburn1,3
1Department of Ophthalmology, Gavin Herbert Eye Institute, University of California Irvine, Irvine, CA, USA.
Abstract:
Mitochondrial-derived peptides (MDPs) are rapidly emerging therapeutic targets to combat development of neurodegenerative diseases. SHLP2 (small humanin-like peptide 2) is a newly discovered MDP that is coded from the MT-RNR2 (Mitochondrially encoded 16S rRNA) gene in mitochondrial DNA (mtDNA). In the current study, we examined the biological consequences of treatment with exogenously-added SHLP2 in an in vitro human transmitochondrial age-related macular degeneration (AMD) ARPE-19 cell model. In AMD cells, we observed significant down-regulation of the MDP-coding MT-RNR2 gene, and remarkably reduced levels of all five oxidative phosphorylation (OXPHOS) complex I-V protein subunits that are involved in the electron transport chain; these results suggested mitochondrial toxicity and abnormal OXPHOS complex protein subunits' levels in AMD cells. However, treatment of AMD cells with SHLP2: (1) restored the normal levels of OXPHOS complex protein subunits, (2) prevented loss of viable cells and mitochondria, (3) increased the number of mtDNA copies, (4) induced anti-apoptotic effects, and (5) attenuated amyloid-β-induced cellular and mitochondrial toxicity. Cumulatively, our findings established the protective role of SHLP2 in AMD cells in vitro. In conclusion, this novel study supports the merit of SHLP2 in the treatment of AMD, a primary retinal disease that is a leading cause of blindness among the elderly population in the United States as well as worldwide.
Insights
Small humanin-like peptide 2 (SHLP2), a mitochondrial-derived peptide, protects against age-related macular degeneration (AMD) by restoring mitochondrial function and preventing cell death. This peptide shows therapeutic potential for AMD treatment.
Area of Science:
- Mitochondrial biology
- Neurodegenerative diseases
- Ophthalmology
Background:
- Mitochondrial-derived peptides (MDPs) are emerging therapeutic targets for neurodegenerative diseases.
- SHLP2 is a novel MDP encoded by the MT-RNR2 gene in mitochondrial DNA (mtDNA).
- Age-related macular degeneration (AMD) is a leading cause of blindness associated with mitochondrial dysfunction.
Purpose of the Study:
- To investigate the protective effects of exogenously-added SHLP2 in an in vitro human ARPE-19 cell model of AMD.
- To determine if SHLP2 can counteract mitochondrial toxicity and oxidative stress observed in AMD cells.
Main Methods:
- Utilized an in vitro human transmitochondrial ARPE-19 cell model of AMD.
- Assessed the impact of SHLP2 treatment on oxidative phosphorylation (OXPHOS) complex protein subunits, cell viability, mitochondrial integrity, mtDNA copy number, and apoptosis.
- Evaluated SHLP2's efficacy in attenuating amyloid-β-induced toxicity.
Main Results:
- AMD cells exhibited down-regulated MT-RNR2 and reduced OXPHOS complex protein subunits, indicating mitochondrial toxicity.
- SHLP2 treatment restored OXPHOS protein levels, preserved cell and mitochondrial viability, and increased mtDNA copy number.
- SHLP2 demonstrated anti-apoptotic effects and attenuated amyloid-β-induced cellular and mitochondrial damage in AMD cells.
Conclusions:
- SHLP2 plays a significant protective role in an in vitro model of AMD.
- This study supports the therapeutic potential of SHLP2 for treating age-related macular degeneration.
- SHLP2 represents a promising novel therapeutic strategy for AMD, a major cause of age-related vision loss.
More Related Videos
Related Concept Videos
Animal Mitochondrial Genetics
Peptide Bonds
Export of Mitochondrial and Chloroplast Genes
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
Directing and Steric Effects in Disubstituted Benzene Derivatives
Protection of Alcohols
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...

